Hepacellular Carcinoma research hub

ImmunoTACE

This study is testing a new way to treat liver cancer. Doctors are looking at combining a standard treatment called TACE—which targets the tumour directly—with a low-dose chemotherapy drug and a cancer vaccine. The goal is to see if this helps the immune system fight the cancer more effectively.